Clinical Trial Update: Evaluation of (Doravirine / Lamivudine / Tenofovir Disoproxil Fumarate) (Delstrigo®) as a New Strategy for Non-occupational Post Exposure Prophylaxis, a Prospective Open Label Study [Phase 4]

View source ↗

Summary

Prospective open-label Phase 4 trial evaluating Delstrigo (doravirine/lamivudine/tenofovir disoproxil fumarate) as a non-occupational post-exposure prophylaxis …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• DELSTRIGO (DORAVIRINE, LAMIVUDINE, TENOFOVIR DISOPROXIL FUMARATE)

Snippet

Sponsor: Hospital Clinic of Barcelona | Conditions: Hiv | Phase 4 | Status: COMPLETED | Results posted: 2025-09-10